{"a":[{"_":"Insilico’s Chinese partner returns for $177M pact to explore ‘mass market’ CNS indication ","$":{"href":"/biotech/insilicos-chinese-partner-returns-177m-pact-explore-mass-market-cns-indication","hreflang":"en"}}]}

Summary

China Medical System Holdings and Insilico have entered a $177 million collaboration to develop a CNS indication described as a 'mass-market' therapeutic target. This represents an expansion of the existing partnership between the two companies.